ROCAMBOLI STEPHEN 4
4 · Esperion Therapeutics, Inc. · Filed May 27, 2022
Insider Transaction Report
Form 4
ROCAMBOLI STEPHEN
Director
Transactions
- Award
Stock Option (right to buy)
2022-05-26+1,589→ 1,589 totalExercise: $5.51Exp: 2032-05-26→ Common Stock (1,589 underlying) - Award
Stock Option (right to buy)
2022-05-26+40,000→ 40,000 totalExercise: $5.51Exp: 2032-05-26→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]The awards vest over a three (3) year period in equal annual installments, the first of which will be May 26, 2023.
- [F2]The awards vest in full on the earlier of (i) May 26, 2023 and (ii) the Issuer's next annual meeting of stockholders following May 26, 2022.